Henning Steinhagen

Henning is a senior executive and entrepreneur with more than 20 years of operational experience in Pharma, Biotech and Venture capital. He is currently Venture Partner at Epidarex and co-founder and CEO of Epidarex Exeed Ltd. Previously, Henning served as President R&D at Aptuit, a leading R&D organization. As a member of the executive committee he led the growth and transformation including a successful $300m exit.

Prior to that he acted as SVP and Head of Global Drug Discovery at Grünenthal and held senior roles at Sanofi-Aventis and Bayer Pharma.

In 2018 Henning completed an executive MBA at the IMD in Lausanne. He holds a PhD in Chemistry with an additional degree in Molecular Genetics. Henning worked with Nobel laureate Prof. E.J. Corey at Harvard and holds an Adjunct Professorship from Trinity College Dublin.